Work

PIK3CA mutations contribute to fulvestrant resistance in ER-positive breast cancer.

Year: 2019
Type: article
Abstract: mutations could not only confer to fulvestrant resistance, but also promote cell proliferation and migration. Inhibition of corresponding activated pathways could effectively suppress cell growth.
Source: PubMed
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W2985804592
FWCI: 1.301
Cites: 32
Cited by: 31
Related to: 8